Replies to post #1372 on Idenix Pharmaceuticals (IDIX)

[keitern]

>>Ergo I would assume that it "does not match" the competition in the efficacy/convenience/side-effects paradigm - otherwise it would not carry the stigma of the disount. <<

What about the safety and efficacy data from the trials? Is it invalid?